Cypress Capital Management (Delaware)’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,455
| Closed | -$2.26M | – | 156 |
|
|
2022
Q3 | $2.26M | Buy |
4,455
+1,225
| +38% | +$621K | 0.42% | 59 |
|
|
2022
Q2 | $1.76M | Hold |
3,230
| – | – | 0.26% | 73 |
|
|
2022
Q1 | $1.91M | Hold |
3,230
| – | – | 0.24% | 80 |
|
|
2021
Q4 | $2.16M | Buy |
3,230
+175
| +6% | +$117K | 0.24% | 82 |
|
|
2021
Q3 | $1.54M | Hold |
3,055
| – | – | 0.2% | 81 |
|
|
2021
Q2 | $1.54M | Hold |
3,055
| – | – | 0.2% | 82 |
|
|
2021
Q1 | $1.39M | Hold |
3,055
| – | – | 0.19% | 84 |
|
|
2020
Q4 | $1.42M | Hold |
3,055
| – | – | 0.19% | 82 |
|
|
2020
Q3 | $1.35M | Sell |
3,055
-500
| -14% | -$221K | 0.21% | 79 |
|
|
2020
Q2 | $1.29M | Hold |
3,555
| – | – | 0.21% | 79 |
|
|
2020
Q1 | $1.01M | Hold |
3,555
| – | – | 0.2% | 78 |
|
|
2019
Q4 | $1.16M | Hold |
3,555
| – | – | 0.18% | 86 |
|
|
2019
Q3 | $1.04M | Hold |
3,555
| – | – | 0.17% | 84 |
|
|
2019
Q2 | $1.04M | Sell |
3,555
-150
| -4% | -$44.1K | 0.18% | 83 |
|
|
2019
Q1 | $1.01M | Buy |
3,705
+30
| +0.8% | +$8.21K | 0.19% | 80 |
|
|
2018
Q4 | $822K | Hold |
3,675
| – | – | 0.17% | 78 |
|
|
2018
Q3 | $897K | Hold |
3,675
| – | – | 0.16% | 76 |
|
|
2018
Q2 | $761K | Buy |
+3,675
| New | +$761K | 0.14% | 89 |
|
|
2018
Q1 | – | Sell |
-1,349
| Closed | -$256K | – | 147 |
|
|
2017
Q4 | $256K | Sell |
1,349
-1
| -0.1% | -$190 | 0.05% | 131 |
|
|
2017
Q3 | $255K | Sell |
1,350
-120
| -8% | -$22.7K | 0.05% | 120 |
|
|
2017
Q2 | $256K | Hold |
1,470
| – | – | 0.06% | 106 |
|
|
2017
Q1 | $226K | Hold |
1,470
| – | – | 0.06% | 107 |
|
|
2016
Q4 | $207K | Buy |
+1,470
| New | +$207K | 0.05% | 105 |
|